Chlorozotocin
Jump to navigation
Jump to search
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C9H16ClN3O7 |
Molar mass | 313.69 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Chlorozotocin is a nitrosourea. It is used for cancer therapy.[citation needed]
The International Agency for Research on Cancer concluded it was "probably carcinogenic" in 1990[1]
It is an analogue of streptozotocin.[2]
References
- ^ Humans, IARC Working Group on the Evaluation of Carcinogenic Risk to (1990). SUMMARY OF FINAL EVALUATIONS. International Agency for Research on Cancer.
- ^ Wolfe MM (2006). Therapy of digestive disorders. Elsevier Health Sciences. p. 477. ISBN 978-1-4160-0317-5.
Categories:
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from May 2020
- Drugs not assigned an ATC code
- Articles with changed ChemSpider identifier
- Articles with changed KEGG identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All articles with unsourced statements
- Articles with unsourced statements from July 2011
- Alkylating antineoplastic agents
- IARC Group 2A carcinogens
- Monosaccharide derivatives
- Nitrosoureas
- Chloroethyl compounds
- All stub articles
- Antineoplastic and immunomodulating drug stubs